Pharmaceutical Manufacturer Invests $8.5 Million To Expand Its North Carolina Plant
01/03/2013
Exela Pharma Sciences develops and manufactures injectable and ophthalmic pharmaceutical products. The company currently employs more than 40 at its Lenoir facility.
“Exela is pleased to be in a position to pursue its expansion plans and create these high paying jobs in Caldwell County,” said Phanesh Koneru, Exela’s president and CEO. “Exela is thankful to the officials of the City of Lenoir, Caldwell County, and the State of North Carolina for their continued support of Exela’s business.”
According to Gov. Bev Perdue the project was made possible in part by an $189,000 grant from the One North Carolina Fund. “North Carolina has a proud and celebrated history in manufacturing,” said Gov. Perdue. “North Carolina’s biotech industry is thriving because of our highly-skilled workforce and strong business climate.”
The One NC Fund provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs in the state. Companies receive no money up front and must meet job creation and investment performance standards to qualify for grant funds. These grants also require and are contingent upon local matches.
Project Announcements
ACG Plans Conyers, Georgia, Manufacturing Operations
10/30/2025
AlphaGraphics KC Expands Kansas City, Missouri, Operations
10/30/2025
Merck & Co. Expands Elkton, Virginia, Manufacturing Operations
10/28/2025
Tate Plans Glasgow, Kentucky, Manufacturing Operations
10/28/2025
Electrolux Consumer Products Expands Kinston, North Carolina, Manufacturing Operations
10/28/2025
Canada-Based MST Rebar Plans Bladenboro, North Carolina, Manufacturing Operations
10/28/2025
Most Read
- 
        2025’s Top States for Business: How the Winners Are Outpacing the RestQ3 2025
- 
        The Compliance Reckoning Is HereQ3 2025
- 
        Around the Horn: Data Center Supply Chains — What's Next?Q3 2025
- 
        How Consumer Trends Are Reshaping Food FacilitiesQ3 2025
- 
        Powering the Next Generation of ProjectsQ3 2025
- 
        First Person: Filter King’s Expansion PlaybookQ3 2025
- 
        Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain ShiftsQ3 2025